Impact of Gentamicin-Collagen sponge (Collatamp) on the incidence of sternal wound infection in high-risk cardiac surgery patients: A propensity score analysis

Heart Surgery Forum

Volumn 15, Issue 5, 2012, Pages

  Raja, Shahzad G ^a   Salhiyyah, Kareem ^a   Rafiq, Muhammed Umar ^a   Felderhof, Jeremy ^a   Amrani, Mohamed ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN SPONGE; GENTAMICIN;

ARTICLE; CONTROLLED STUDY; HEART SURGERY; HEMOFILTRATION; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTRAAORTIC BALLOON PUMP; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPENSITY SCORE; STERNAL WOUND INFECTION; SURGICAL PATIENT; WOUND CARE; WOUND INFECTION;

AGED; CARDIAC SURGICAL PROCEDURES; COHORT STUDIES; COLLAGEN; CONFIDENCE INTERVALS; DRUG DELIVERY SYSTEMS; FEMALE; FOLLOW-UP STUDIES; GENTAMICINS; HUMANS; INCIDENCE; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STERNOTOMY; SURGICAL SPONGES; SURGICAL WOUND INFECTION; TREATMENT OUTCOME; WOUND CLOSURE TECHNIQUES; WOUND HEALING;

EID: 84868241280     PISSN: 10983511     EISSN: 15226662     Source Type: Journal    
DOI: 10.1532/HSF98.20121032     Document Type: Article

References (22)

1. Ariyaratnam P, Bland M, Loubani M. 2010. Risk factors and mortality associated with deep sternal wound infections following coronary bypass surgery with or without concomitant procedures in a UK population: a basis for a new risk model? Interact Cardiovasc Thorac Surg 11:543-6.
2. Austin PC. 2007. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thorac Cardiovasc Surg 134:1128-35.
3. Beckmann A, Doebler K, Schaefer E, Koetting J, Gastmeier P, Graf K. 2011. Sternal surgical site infection prevention-is there any room for improvement? Eur J Cardiothorac Surg 40:347-51.
4. Bendavid R. 1997. The Shouldice technique: a canon in hernia repair. Can J Surg 40:199-205.
5. Bennett-Guerrero E, Ferguson TB Jr, et al, for the SWIPE-1 Trial Group. 2010. Effect of an implantable gentamicin-collagen sponge on sternal wound infections following cardiac surgery: a randomized trial. JAMA 304:755-62.
6. Blaser J, Stone BB, Groner MC, Zinner SH. 1987. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrob Agents Che-mother 31:1054-60. (Pubitemid 17099578)
7. Borger MA, Rao V, Weisel RD, et al. 1998. Deep sternal wound infection: risk factors and outcomes. Ann Thorac Surg 65:1050-6.
8. Cayci C, Russo M, Cheema FH, et al. 2008. Risk analysis of deep sternal wound infections and their impact on long-term survival: a propensity analysis. Ann Plast Surg 61:294-301.
9. Chvapil M. Collagen sponge: theory and practice of medical applications. 1977. J Biomed Mater Res 11:721-41. (Pubitemid 8159589)
10. Corn T. 2010. Treating sternal wound infections after cardiac surgery with an implantable gentamicin-collagen sponge. JAMA 304:2123; author reply 2124.
11. de Bruin A F, Gosselink M P, van der Harst E, Rutten HJ. 2010. Local application of gentamicin collagen implants in the prophylaxis of surgical site infections following gastrointestinal surgery: a review of clinical experience. Tech Coloproctol 14:301-10.
12. Douville EC, Asaph JW, Dworkin RJ, et al. 2004. Sternal preservation: a better way to treat most sternal wound complications after cardiac surgery. Ann Thorac Surg 78:1659-64. (Pubitemid 39423533)
13. Eklund A, Valtonen M, Werkkala K. 2005. Prophylaxis of sternal wound infections with gentamicin-collagen implant: randomized controlled study in cardiac surgery. J Hosp Infect 59:108-12. (Pubitemid 40058036)
14. Friberg Ö, Svedjeholm R, Söderquist B, Granfeldt H, Vikerfors T, Käll-man J. 2005. Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial. Ann Thorac Surg 79:153-61.
15. Fynn-Thompson F, Vander Salm TJ. 2004. Methods for reduction of sternal wound infection. Semin Thorac Cardiovasc Surg 16:77-80. (Pubitemid 38714763)
16. Kinel FA, Ciaccio LA, Henderson SB. 1984. Sustained release preparations, XVI: collagen as a drug carrier. Arch Pharm 317:657-61. (Pubitemid 14053290)
17. Lazar HL, Barlam T, Cabral H. 2011. The effect of topical vancomy-cin applied to sternotomy incisions on postoperative serum vancomycin levels. J Card Surg 26:461-5.
18. Moore RD, Lietman PS, Smith CR. 1987. Clinical response to amino-glycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 155:93-9. (Pubitemid 17225088)
19. Parsons LS. 2001. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Proceedings of the Twenty-sixth Annual SAS Users Group International Conference 2001, SAS Institute Inc., Cary, NC, April 22-25, 2001.
20. Schimmer C, Ozkur M, Sinha B, et al. 2012. Gentamicin-collagen sponge reduces sternal wound complications after heart surgery: a controlled, prospectively randomized, double-blind study. J Thorac Cardiovasc Surg 143:194-200.
21. Stemberger A, Grimm H, Bader F, Rahn HD, Ascherl R. 1997. Local treatment of bone and soft tissue infections with the collagen-gentamicin sponge. Eur J Surg S578:17-26. (Pubitemid 27213784)
22. Vander Salm TJ, Okike ON, Pasque MK, et al. 1989. Reduction of sternal infection by application of topical vancomycin. J Thorac Cardiovasc Surg 98:618-22. (Pubitemid 19248898)